✦ LIBER ✦

PCN40 COST EFFECTIVENESS OF RITUXIMAB PLUS CVP IN PREVIOUSLY UNTREATED INDOLENT NON-HODGKIN'S LYMPHOMA

✍ Scribed by B Maturi; W Tong; M Gyldmark; J Creeden; R Aultman; FJ Jost

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A quality-adjusted survival analysis (Q-

✍ Marcus, R; Aultman, R; Jost, F 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 264 KB

PCN28 COST-EFFECTIVENESS ANALYSIS OF RIT

✍ D Cortina; R Rivera-Hurtado; C Aleman; I Egoavil; L Gonzalez-Michaca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCH7: COST-EFFECTIVENESS OF RITUXIMAB IN

✍ MJ Cattaneo; MB Nichol 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PCN29 COST-EFFECTIVENESS OF MAINTENANCE

✍ F Kasteng; M Erlanson; H Hagberg; E Kimby; T Relander; J Lundkvist 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Cost-Effectiveness Of Bendamustine+Ritux

✍ Lachaine, J.; Beauchemin, C.; Mathurin, K.; Aissa, F. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

The Cost-Effectiveness of Bendamustine-R

✍ Bertwistle, D.; Munakata, J.; Wehler, E.; Leyva, V.; Valencia, A.; Hernandez, A. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB